These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Intestinal microbiota, diet and health. Power SE; O'Toole PW; Stanton C; Ross RP; Fitzgerald GF Br J Nutr; 2014 Feb; 111(3):387-402. PubMed ID: 23931069 [TBL] [Abstract][Full Text] [Related]
27. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781 [TBL] [Abstract][Full Text] [Related]
28. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Pickard JM; Zeng MY; Caruso R; Núñez G Immunol Rev; 2017 Sep; 279(1):70-89. PubMed ID: 28856738 [TBL] [Abstract][Full Text] [Related]
29. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. van Baarlen P; Wells JM; Kleerebezem M Trends Immunol; 2013 May; 34(5):208-15. PubMed ID: 23485516 [TBL] [Abstract][Full Text] [Related]
30. Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine. Maeda Y; Kurakawa T; Umemoto E; Motooka D; Ito Y; Gotoh K; Hirota K; Matsushita M; Furuta Y; Narazaki M; Sakaguchi N; Kayama H; Nakamura S; Iida T; Saeki Y; Kumanogoh A; Sakaguchi S; Takeda K Arthritis Rheumatol; 2016 Nov; 68(11):2646-2661. PubMed ID: 27333153 [TBL] [Abstract][Full Text] [Related]
31. Oral bacteria affect the gut microbiome and intestinal immunity. Kobayashi R; Ogawa Y; Hashizume-Takizawa T; Kurita-Ochiai T Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32504490 [TBL] [Abstract][Full Text] [Related]
32. Gut biofilm forming bacteria in inflammatory bowel disease. Srivastava A; Gupta J; Kumar S; Kumar A Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174 [TBL] [Abstract][Full Text] [Related]
33. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Gaboriau-Routhiau V; Rakotobe S; Lécuyer E; Mulder I; Lan A; Bridonneau C; Rochet V; Pisi A; De Paepe M; Brandi G; Eberl G; Snel J; Kelly D; Cerf-Bensussan N Immunity; 2009 Oct; 31(4):677-89. PubMed ID: 19833089 [TBL] [Abstract][Full Text] [Related]
34. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Benakis C; Brea D; Caballero S; Faraco G; Moore J; Murphy M; Sita G; Racchumi G; Ling L; Pamer EG; Iadecola C; Anrather J Nat Med; 2016 May; 22(5):516-23. PubMed ID: 27019327 [TBL] [Abstract][Full Text] [Related]
35. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Schaubeck M; Clavel T; Calasan J; Lagkouvardos I; Haange SB; Jehmlich N; Basic M; Dupont A; Hornef M; von Bergen M; Bleich A; Haller D Gut; 2016 Feb; 65(2):225-37. PubMed ID: 25887379 [TBL] [Abstract][Full Text] [Related]
36. High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice. Okai S; Usui F; Yokota S; Hori-I Y; Hasegawa M; Nakamura T; Kurosawa M; Okada S; Yamamoto K; Nishiyama E; Mori H; Yamada T; Kurokawa K; Matsumoto S; Nanno M; Naito T; Watanabe Y; Kato T; Miyauchi E; Ohno H; Shinkura R Nat Microbiol; 2016 Jul; 1(9):16103. PubMed ID: 27562257 [TBL] [Abstract][Full Text] [Related]
37. An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease? Burman S; Hoedt EC; Pottenger S; Mohd-Najman NS; Ó Cuív P; Morrison M Dig Dis; 2016; 34(1-2):64-71. PubMed ID: 26982568 [TBL] [Abstract][Full Text] [Related]
38. Intestinal dysbiosis in inflammatory bowel disease. Kaur N; Chen CC; Luther J; Kao JY Gut Microbes; 2011; 2(4):211-6. PubMed ID: 21983063 [TBL] [Abstract][Full Text] [Related]
39. [Enteric microflora in inflammatory bowel disease patients]. Rahmouni O; Dubuquoy L; Desreumaux P; Neut C Med Sci (Paris); 2016 Nov; 32(11):968-973. PubMed ID: 28008837 [TBL] [Abstract][Full Text] [Related]
40. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Gobert AP; Sagrestani G; Delmas E; Wilson KT; Verriere TG; Dapoigny M; Del'homme C; Bernalier-Donadille A Sci Rep; 2016 Dec; 6():39399. PubMed ID: 27982124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]